Cutler Group LP Adamis Pharmaceuticals Corp Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$2.02 - $3.22 $13,067 - $20,830	-6,469 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$2.1 - $3.21 $1,050 - $1,605	-500 Reduced 7.17%	6,469 $14,000
Q3 2018 Nov 07, 2018	BUY	$2.25 - $4.8 $15,075 - $32,160	6,700 Added 2490.71%	6,969 $24,000
Q2 2018 Aug 10, 2018	SELL	$3.2 - $4.7 $1,920 - $2,820	-600 Reduced 69.04%	269 $0
Q1 2018 May 11, 2018	SELL	$2.55 - $4.85 $5,610 - $10,670	-2,200 Reduced 71.68%	869 $3,000
Q4 2017 Jan 17, 2018	BUY	$3.5 - $5.65 $7,700 - $12,430	2,200 Added 253.16%	3,069 $13,000
Q3 2017 Oct 17, 2017	BUY	$4.5 - $5.65 $3,910 - $4,909	869	869 $4,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.